1. Identification of novel prognostic factors focusing on clinical outcomes in patients with non‑small cell lung cancer after stereotactic body radiotherapy
   Hikari Sato et al, 2022, Oncology Letters CrossRef
2. Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levels
   Naoya Ishibashi et al, 2022, Thoracic Cancer CrossRef
3. Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot study
   W.M. Szejniuk et al, 2019, Clinical and Translational Radiation Oncology CrossRef
4. Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
   Li Xu et al, 2019, Cancer Medicine CrossRef
5. Markers Useful in Monitoring Radiation-Induced Lung Injury in Lung Cancer Patients: A Review
   Mariola Śliwińska-Mossoń et al, 2020, Journal of Personalized Medicine CrossRef